Moreover, clinical studies of BTZ in children with relapsed and refractory ALL showed promising results with combination regimens including mitoxantrone, vincristine, asparaginase, doxorubicin, and dexamethasone [14,15,16,17]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.